677 related articles for article (PubMed ID: 19200271)
21. An approach to heart failure and diabetes mellitus.
Fonarow GC
Am J Cardiol; 2005 Aug; 96(4A):47E-52E. PubMed ID: 16098844
[TBL] [Abstract][Full Text] [Related]
22. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
Lim S
Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
[TBL] [Abstract][Full Text] [Related]
23. Managing chronic heart failure patient in chronic kidney disease.
Abdo AS; Basu A; Geraci SA
Am J Med; 2011 Jan; 124(1):26-8. PubMed ID: 20932501
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic advances in long-term heart failure management.
Pfeffer MA
Am Heart Hosp J; 2004; 2(4 Suppl 1):15-20. PubMed ID: 15539971
[TBL] [Abstract][Full Text] [Related]
25. [Heart failure in chronic kidney disease: from epidemiology to therapy].
Zamboli P; De Nicola L; Minutolo R; Stanzione G; Bertino V; Sosio R; De Luca A; Crivaro M; Tassinario S; Conte G
G Ital Nefrol; 2007; 24(6):574-83. PubMed ID: 18278761
[TBL] [Abstract][Full Text] [Related]
26. Drug treatment for chronic systolic heart failure.
Mörike K; Sindermann JR
Thorac Cardiovasc Surg; 2010 Feb; 58 Suppl 2():S170-2. PubMed ID: 20101534
[TBL] [Abstract][Full Text] [Related]
27. Conclusions on the management of heart failure.
Swedberg K
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S34-6. PubMed ID: 15526241
[TBL] [Abstract][Full Text] [Related]
28. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
Sinagra G; Sabbadini G; Zecchin M; Di Lenarda A
G Ital Cardiol (Rome); 2007 Sep; 8(9):559-67. PubMed ID: 17972425
[TBL] [Abstract][Full Text] [Related]
29. Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study.
Störk S; Hense HW; Zentgraf C; Uebelacker I; Jahns R; Ertl G; Angermann CE
Eur J Heart Fail; 2008 Dec; 10(12):1236-45. PubMed ID: 18996739
[TBL] [Abstract][Full Text] [Related]
30. Management of chronic heart failure: an old disease with a new face.
Prendergast HM; Bunney EB
Emerg Med Australas; 2005 Apr; 17(2):143-51. PubMed ID: 15796729
[TBL] [Abstract][Full Text] [Related]
31. Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.
Norgard NB; Stark JE
Pharmacotherapy; 2008 Jul; 28(7):920-31. PubMed ID: 18576907
[TBL] [Abstract][Full Text] [Related]
32. [Impact of comorbidities for the treatment of heart failure].
Laperche T
Rev Prat; 2010 Sep; 60(7):955-9. PubMed ID: 21033494
[TBL] [Abstract][Full Text] [Related]
33. Pharmacologic therapies across the continuum of left ventricular dysfunction.
Abraham WT; Greenberg BH; Yancy CW
Am J Cardiol; 2008 Sep; 102(5A):21G-28G. PubMed ID: 18722188
[TBL] [Abstract][Full Text] [Related]
34. Filling the gap between guidelines and clinical practice in heart failure treatment: still a far cry from reality.
Remme WJ
Eur J Heart Fail; 2007 Dec; 9(12):1143-5. PubMed ID: 17936067
[No Abstract] [Full Text] [Related]
35. Chronic heart failure.
Poole-Wilson PA
Timely Top Med Cardiovasc Dis; 2007 Jan; 11():E2. PubMed ID: 18297148
[No Abstract] [Full Text] [Related]
36. Angiotensin-converting enzyme inhibitors and outcome among patients with heart failure and renal insufficiency: need for a prospective study.
Smilde TD; Hillege HL; van Veldhuisen DJ; Navis G
J Am Coll Cardiol; 2005 Jun; 45(11):1905. PubMed ID: 15936627
[No Abstract] [Full Text] [Related]
37. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
Rapp JA; Gheorghiade M
Cardiol Clin; 2008 Feb; 26(1):23-40, vi. PubMed ID: 18312903
[TBL] [Abstract][Full Text] [Related]
38. Changes in heart failure medications in patients hospitalised and discharged.
Scherer M; Sobek C; Wetzel D; Koschack J; Kochen MM
BMC Fam Pract; 2006 Nov; 7():69. PubMed ID: 17123439
[TBL] [Abstract][Full Text] [Related]
39. Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment.
Jois P; Mebazaa A
Semin Nephrol; 2012 Jan; 32(1):26-30. PubMed ID: 22365159
[TBL] [Abstract][Full Text] [Related]
40. Use of antagonists of aldosterone in patients with chronic kidney disease: Potential advantages and risks.
Campese VM; Park J
J Hypertens; 2006 Nov; 24(11):2157-9. PubMed ID: 17053534
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
